Xvivo Perfusion AB
XVIVO.ST
#5119
Rank
ยฃ1.00 B
Marketcap
ยฃ32.05
Share price
-0.22%
Change (1 day)
64.20%
Change (1 year)
Categories

Revenue for Xvivo Perfusion AB (XVIVO.ST)

Revenue in 2024 (TTM): ยฃ51.65 Million

According to Xvivo Perfusion AB's latest financial reports the company's current revenue (TTM ) is ยฃ52.22 Million. In 2023 the company made a revenue of ยฃ44.51 Million an increase over the revenue in the year 2022 that were of ยฃ33.56 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Xvivo Perfusion AB from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ51.65 M16.05%
2023 ยฃ44.51 M32.63%
2022 ยฃ33.56 M54.16%
2021 ยฃ21.77 M48.22%
2020 ยฃ14.68 M-17.85%
2019 ยฃ17.87 M6.34%
2018 ยฃ16.81 M28.98%
2017 ยฃ13.03 M-0.33%
2016 ยฃ13.07 M35.46%
2015 ยฃ9.65 M25.8%
2014 ยฃ7.67 M19.52%
2013 ยฃ6.42 M